Abstract |
The agonist of the prostaglandin EP4 receptor can increase bone density in osteoporosis. Using ovariectomized (OVX) and sham-operated (SO) rats, the effects of the EP4 receptor agonist, ONO-4819, and hydroxyapatite (HA) on implant-bone fixation in implants with a rough surface were investigated. Female Wistar rats (12 weeks old) were divided into either SO or bilateral OVX groups. Twenty four weeks later, either hydroxyapatite/ titanium (HA/Ti) composite-coated or Ti-coated implants were implanted into the femora, and the animals were treated with either ONO-4819 or saline for 4 weeks. The fixation strength of the HA/Ti-coated implants was higher than that of the Ti-coated implants in the saline-treated OVX rats. In the OVX rats, ONO-4819 enhanced fixation of the rough Ti-coated implants to levels similar to that of HA/Ti-coated implants. These data suggest that a combination of treatment with an EP4 receptor agonist and a rough-surfaced implant might be useful in increasing the early fixation of cement-less arthroplasty, particularly in elderly patients with osteoporosis.
|
Authors | K Hayashi, A Fotovati, S Abu Ali, Y Nakamura, M Inagaki, M Naito |
Journal | Journal of biomedical materials research. Part A
(J Biomed Mater Res A)
Vol. 92
Issue 3
Pg. 1202-9
(Mar 01 2010)
ISSN: 1552-4965 [Electronic] United States |
PMID | 19322876
(Publication Type: Journal Article)
|
Copyright | (c) 2009 Wiley Periodicals, Inc. |
Chemical References |
- Heptanoates
- ONO4819
- Receptors, Prostaglandin E
- Receptors, Prostaglandin E, EP4 Subtype
- Durapatite
- Titanium
|
Topics |
- Animals
- Durapatite
- Female
- Heptanoates
(pharmacology)
- Ovariectomy
- Prostheses and Implants
- Rats
- Rats, Wistar
- Receptors, Prostaglandin E
(agonists)
- Receptors, Prostaglandin E, EP4 Subtype
- Titanium
- X-Ray Diffraction
|